|Bid||0.0000 x 900|
|Ask||0.0000 x 800|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|Beta (3Y Monthly)||1.59|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Exec. Vice Chairman/CEO/Pres. of Hemispherx Biopharma Inc (HEB) Thomas K. Equels bought 29,404 shares of HEB on 06/21/2019 at an average price of $4.03 a share.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
If you're interested in Hemispherx Biopharma, Inc. (NYSEMKT:HEB), then you might want to consider its beta (a measure...
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We don't wish catastrophic capital loss on anyone. For example, we sympathize with anyone who was caught holding Hemispherx Biop...